Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Looking for value? Find out what credit card has the best rewards and no annual fee to maximize your financial benefits without added costs.
28,655 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
A major bipartisan measure would bar the Federal Reserve from issuing a central bank digital currency, signaling a sh...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
The latest RealTrends verification highlights 2026 GameChangers who turned market disruption into rapid expansion, le...
Scott Galloway weighs in on Kara Swisher's podcast empire and why the industry resembles the NBA: a handful of stars ...
When a large investment firm trims a position, it sends a signal to the market. This article explains what timucuan a...
A debt-free couple earning $100,000 a year reports zero savings, prompting a rare on-air moment of doubt from Dave Ra...
Investors chased space-focused stocks higher on SpaceX IPO speculation, lifting Spacemobile 20%, Planet Labs 15%, and...